These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31206608)

  • 1. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
    Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
    Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.
    Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma.
    Spina M; Balzarotti M; Uziel L; Ferreri AJ; Fratino L; Magagnoli M; Talamini R; Giacalone A; Ravaioli E; Chimienti E; Berretta M; Lleshi A; Santoro A; Tirelli U
    Oncologist; 2012; 17(6):838-46. PubMed ID: 22610154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma.
    Tanaka T; Sakai R; Choi I; Tsukada J; Sasaki H; Naito Y; Kiyomi F; Takamatsu Y; Tamura K
    Sci Rep; 2022 Feb; 12(1):3124. PubMed ID: 35210509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comprehensive geriatric assessment can predict the clinical outcomes of elderly patients with diffuse large B cell lymphoma in China].
    Zhang CL; Feng R; Li JT; Tian Y; Wang T; Liu H
    Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):271-276. PubMed ID: 29779319
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of elderly patients with diffuse large B-cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment.
    Yoshida M; Nakao T; Horiuchi M; Ueda H; Hagihara K; Kanashima H; Inoue T; Sakamoto E; Hirai M; Koh H; Nakane T; Hino M; Yamane T
    Eur J Haematol; 2016 Apr; 96(4):409-16. PubMed ID: 26084899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
    Cox MC; Pelliccia S; Marcheselli L; Battistini R; Arcari A; Borza PA; Patti C; Casaroli I; di Landro F; Di Napoli A; Fabbri F; Caridi M; Tafuri A; Bocci G; Musuraca G
    Invest New Drugs; 2019 Jun; 37(3):548-558. PubMed ID: 31028663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
    Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
    Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the
    Storti S; Spina M; Pesce EA; Salvi F; Merli M; Ruffini A; Cabras G; Chiappella A; Angelucci E; Fabbri A; Liberati AM; Tani M; Musuraca G; Molinari A; Petrilli MP; Palladino C; Ciancia R; Ferrario A; Gasbarrino C; Monaco F; Fraticelli V; De Vellis A; Merli F; Luminari S
    Haematologica; 2018 Aug; 103(8):1345-1350. PubMed ID: 29748444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
    Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
    Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
    Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
    Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of comprehensive geriatric assessment in patients aged 80 years and older with diffuse large B-cell lymphoma receiving rituximab-mini-CHOP: a single-institute retrospective study.
    Yamasaki S; Matsushima T; Minami M; Kadowaki M; Takase K; Iwasaki H
    Eur Geriatr Med; 2022 Feb; 13(1):195-201. PubMed ID: 34254266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients.
    Naito Y; Sasaki H; Takamatsu Y; Kiyomi F; Tamura K
    J Clin Exp Hematop; 2016; 56(1):43-9. PubMed ID: 27334857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
    Yagi Y; Kanemasa Y; Sasaki Y; Goto S; Yamamura Y; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
    Ann Hematol; 2023 Jun; 102(6):1485-1500. PubMed ID: 37115298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
    Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
    Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
    Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.
    Liu H; Zhang CL; Feng R; Li JT; Tian Y; Wang T
    Oncologist; 2018 Jun; 23(6):722-729. PubMed ID: 29317552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma.
    Laribi K; Denizon N; Bolle D; Truong C; Besançon A; Sandrini J; Anghel A; Farhi J; Ghnaya H; Baugier de Materre A
    Ann Hematol; 2016 Oct; 95(10):1705-14. PubMed ID: 27485454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy.
    Chou WC; Chang H; Wang PN; Kuo MC; Wu JH; Lin TL; Su YJ; Kao HW; Ou CW; Hung CY; Hsueh SW; Hung YS
    Eur J Haematol; 2020 Oct; 105(4):399-407. PubMed ID: 32472712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curing diffuse large B-cell lymphomas in elderly patients.
    Moccia AA; Thieblemont C
    Eur J Intern Med; 2018 Dec; 58():14-21. PubMed ID: 30472108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.